5-fluorouracil toxicity - DPYD genotyping (4 hot spot mutations - DPYD*2A, DPYD*13, D949V, HapB3) - Pharmacogenetics

Genetic test Export to PDF
Full name:
5-fluorouracil toxicity - DPYD genotyping (4 hot spot mutations - DPYD*2A, DPYD*13, D949V, HapB3) - Pharmacogenetics
Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Therapeutic Management
Specimen:
Peripheral (whole) blood on EDTA
Method category:
Method technique:
Laboratory:
RIZIV code:
EQA:
  • 2015 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2016 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2017 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2018 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2019 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2020 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2022 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2023 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
Turnaround time (maximum):
10 days
Document(s):
Created:
06 Nov 2019 - 13:03
Changed:
19 Jan 2024 - 11:23